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The epidermal growth factor receptor (EGFR)3/ErbB family
of receptor tyrosine kinases (RTKs) contains four member
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proteins: EGFR/ErbB1, HER2/ErbB2/neu, HER3/ErbB3, and
HER4/ErbB4. These RTKs carry out important signaling functions via the sequential process of ligand binding by the extracellular domain, homo- or heterodimerization, activation of
their intracellular kinase domain, and recruitment of downstream signaling proteins. These RTKs are also important
oncogenic drivers in many breast, lung, and other human cancers (1). Several structural biology studies on the ErbB family
have been published, and this has helped advance drug development for HER2-positive breast cancer (2). Protein crystallography studies published in 2004 showed the structure of pertuzumab bound to the extracellular domain of HER2 and
lapatinib bound to the kinase domain of EGFR (3, 4). Since that
time, growing structural biology-based understanding of how
EGFR, HER2, and HER3 function at the atomic level has dramatically reshaped our understanding of RTKs (1, 2). Despite
these advances, there is a domain in each EGFR/ErbB family
protein for which little structural biology information is available; this domain is the C-terminal tail (CTT) domain. The
CTTs contain numerous autophosphorylation sites that are
essential for recruiting downstream signaling proteins and initiating intracellular signaling (5, 6). The CTT can also contribute to autoinhibition of the kinase domain of RTK (7). The lack
of available crystallographic information on the CTT region of
EGFR/ErbB family RTKs led us to examine whether these proteins lack a stable secondary and/or tertiary structure.
Intrinsically disordered regions (IDRs) represent an emerging area of interest in medicine. IDRs are regions within proteins that exhibit high flexibility and may lack a secondary or
tertiary structure but are still able to carry out important biological functions (8 –15). Algorithm prediction methods indicate that around 25–30% of eukaryotic proteins can be categorized as having disordered regions (16). These disordered
regions provide certain advantages in protein-protein interactions, including a larger hydrodynamic radius (17, 18), faster
on- and off-rates of binding (19), high binding specificity (20),
and the ability to adopt different conformations depending on
the binding partner (9, 21). Correlation studies have revealed

tor of natural disordered regions; DLS, dynamic light scattering; ICH, intracellular half; ␤R, regular ␤-strand; ␤D, distorted ␤-strand; RH, hydrodynamic
radius; Rg, radius of gyration; Dmax, maximum interatomic distance; QF,
quench flow; ML, manual labeling; IPTG, isopropyl ␤-D-1-thiogalactopyranoside; FL, flow-through; ␣R, regular ␣-helix; ␣D, distorted ␣-helix.
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The epidermal growth factor receptor (EGFR)/ErbB family of
receptor tyrosine kinases includes oncogenes important in the
progression of breast and other cancers, and they are targets for
many drug development strategies. Each member of the ErbB
family possesses a unique, structurally uncharacterized C-terminal tail that plays an important role in autophosphorylation
and signal propagation. To determine whether these C-terminal
tails are intrinsically disordered regions, we conducted a battery
of biophysical experiments on the EGFR and HER3 tails. Using
hydrogen/deuterium exchange mass spectrometry, we measured the conformational dynamics of intracellular half constructs and compared the tails with the ordered kinase domains.
The C-terminal tails demonstrate more rapid deuterium
exchange behavior when compared with the kinase domains.
Next, we expressed and purified EGFR and HER3 tail-only constructs. Results from circular dichroism spectroscopy, size
exclusion chromatography with multiangle light scattering,
dynamic light scattering, analytical ultracentrifugation, and
small angle X-ray scattering each provide evidence that the
EGFR and HER3 C-terminal tails are intrinsically disordered
with extended, non-globular structure in solution. The intrinsic
disorder and extended conformation of these tails may be
important for their function by increasing the capture radius
and reducing the thermodynamic barriers for binding of downstream signaling proteins.

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered

Results
Disorder Predictions on EGFR, HER2, and HER3—We used
computation algorithms to provide an initial survey of disordered regions in the EGFR/ErbB family of RTKs. Predictor of
natural disordered regions (PONDR) is a collection of algorithms that use an amino acid sequence to predict native disor-

598 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 1. Disorder prediction by PONDR VL-XT algorithm. Shown are the
disorder predictions for EGFR, HER2, and HER3 ICD construct sequences. In all
three graphs, results for the kinase domain residues are colored blue, and the
tail domain residues are colored in red. A score above 0.5 indicates predicted
disorder, whereas a score below 0.5 indicates predicted order.

der (29, 30). The VL-XT algorithm assigns a disorder propensity score for disorder on a residue by residue basis (29 –31).
The VL-XT prediction for EGFR, HER2, and HER3 can be seen
in Fig. 1. PONDR scores greater than 0.5 indicate predicted
disorder, and scores less than 0.5 indicate predicted order.
Kinase domains of the three EGFR/ErbB family members show
mostly predicted order, whereas the CTT in each shows large
regions of predicted disorder. The amino acid composition
of the CTT and kinase domains of both EGFR and HER3 is
shown in Table 1. When comparing the CTTs with the kinase
domains in both proteins, we observe that the CTTs are more
enriched in polar, uncharged residues and prolines but relatively depleted in hydrophobic residues. For EGFR, polar,
uncharged residues make up 30.1% of the CTT versus 14.9% of
the kinase domain. Prolines make up 10.6% of the EGFR CTT
versus 5.4% in the kinase domain, and hydrophobic residues
(excluding tyrosine, which can become phosphorylated) are
27.4% of the EGFR CTT versus 38.9% of the kinase domain
(Table 1). Similar values are seen with HER3 CTT (Table 1)
despite its primary sequence divergence from EGFR CTT (22%
sequence identity between EGFR and HER3 CTT; calculated
with Clustal Omega) (74). The lowered hydrophobicity provides a simple explanation as to why the tails would not form a
hydrophobic core and therefore be disordered in an aqueous
environment. These predictions are a useful tool for gaining a
VOLUME 292 • NUMBER 2 • JANUARY 13, 2017
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a high propensity for disordered regions to undergo posttranslational modification, particularly phosphorylation (22).
Because traditional methods, such as NMR and X-ray crystallography, were developed to study stable protein structures,
IDRs have been more difficult to analyze because of difficulties
in obtaining high concentrations or representative protein
crystals (11, 23). Correlation studies suggest a strong association between IDRs and human cancer-associated proteins (24);
therefore, identifying and analyzing IDRs in cancer-related proteins is vital in understanding how they function.
Protein kinases demonstrate a high degree of specificity in
facilitating phosphorylation; however, many are able to perform such interactions with multiple substrate partners (25).
An analysis of the human kinome shows that as many as 83% of
kinase genes contain IDRs, which could facilitate these multiple
interactions. RTKs are involved in more protein-protein interactions than any other kinase group, thus potentially pointing
to the involvement of IDRs in their recognition mechanisms
(26). Multisequence alignment (27) of EGFR/ErbB family RTKs
shows that the kinase domain sequences are highly conserved
between all four family members. However, the CTT regions
are highly divergent between each EGFR/ErbB family member.
One previous study using circular dichroism (CD) spectroscopy indicated that the EGFR CTT is rich in ␣-helical and
␤-sheet content (6), but a later study used coarse grained modeling to show many possible conformations of the EGFR CTT
based on the assumption that it is naturally disordered (28). A
high degree of flexibility in the CTT would provide distinct
advantages to EGFR interaction with downstream Src homology 2 (SH2) and phosphotyrosine-binding domains during signaling functions (6).
In this work, we examine the biophysical properties of the
CTT of EGFR and HER3. The motivation of this study is to
gather structural information on the CTT region to determine
whether the tails are highly dynamic, disordered regions. First,
we measured the conformational dynamics of intracellular half
(ICH) constructs of EGFR/ErbB family members using amide
hydrogen/deuterium exchange mass spectrometry (HDX-MS).
This information is used to compare the CTTs with the kinase
domains. We also expressed and purified EGFR and HER3
CTT-only constructs and demonstrated that they are functional because they are recognized and phosphorylated by
EGFR family kinases and once phosphorylated can be bound by
the Grb2 SH2 domain. Using these CTT constructs, we performed multiple biophysical analyses, including CD spectroscopy, size exclusion chromatography with multiangle light
scattering (SEC-MALS), dynamic light scattering (DLS), analytical ultracentrifugation (AUC), and small angle X-ray scattering (SAXS). The results of these methods support the
hypothesis that the EGFR and HER3 CTTs are IDRs with
extended, non-globular structure in solution.

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered
TABLE 1
EGFR and HER3 amino acid composition analysis by region
AA, amino acid.
Percentage of total sequence
C-terminal tails
AA residue

EGFR

Kinase domain
HER3

EGFR

HER3

%

11.9
5.8
6.2
6.2
30.1

12.4
5.2
2.8
3.0
23.5

4.7
4.4
2.2
3.5
14.9

5.1
3.5
2.2
4.4
15.2

Negative charge
Asp
Glu
Subtotal

8.4
5.3
13.7

5.0
10.5
15.5

4.4
7.9
12.3

4.4
6.6
11.1

Positive charge
Arg
His
Lys
Subtotal

3.5
2.7
2.7
8.8

6.9
3.6
1.7
12.2

7.0
2.5
7.6
17.1

7.0
3.2
6.3
16.5

Hydrophobic (excluding Tyr)
Ala
Val
Ile
Leu
Met
Phe
Trp
Subtotal

6.6
4.9
3.5
6.2
1.3
4.4
0.4
27.4

5.8
3.9
0.6
9.7
3.0
0.8
0.3
24.0

5.7
7.3
7.9
11.1
2.8
2.2
1.9
38.9

6.3
7.9
5.7
12.0
3.2
2.5
2.2
39.9

Tyrosine
Tyr

4.0

3.6

3.5

3.5

Special
Cys
Gly
Pro

1.3
4.0
10.6

1.7
9.4
10.2

1.9
6.0
5.4

1.3
7.3
5.4

general view of disordered regions in a protein sequence, but
direct empirical evidence would better support the hypothesis
of the CTTs as being IDRs.
Hydrogen/Deuterium Exchange Mass Spectrometry of EGFR/
ErbB Family RTKs—HDX-MS is a highly useful technique to
identify and study IDRs (32–36). HDX-MS provides kinetic
information about the exchange rate of amide hydrogen atoms
along the backbone of a protein for solvent deuterons. This rate
of hydrogen/deuterium exchange is affected by factors such as
the presence of strong hydrogen bonds, secondary structure,
and tertiary structure (37– 40). IDRs show very rapid hydrogen/
deuterium exchange rates on the order of milliseconds to seconds (32–36). HDX-MS provides local information about different regions of the protein and readily distinguishes folded,
globular regions from IDRs. We performed HDX-MS experiments by exposing the protein to deuterium oxide (D2O) over
two ranges of time points, 108 –2333 ms using quench flow and
5 s–2 h using manual labeling. HDX was quenched by lowering
pH and rapidly cooling. This was followed by digesting the protein with immobilized pepsin and measuring the mass increase
that results from incorporation of deuterons into peptic peptides by MS. In this study, we present HDX data as %nex, a
percentage of the maximum observable mass increase. %nex
is based on the number of amide hydrogens available for
exchange and the H2O:D2O ratio during the labeling step.
We show that hydrogen/deuterium exchange occurs more
rapidly in peptides from the CTT than those from the kinase
JANUARY 13, 2017 • VOLUME 292 • NUMBER 2

domain (Fig. 2). Many peptides from the kinase domains
(shown in blue) do not reach a maximum exchange plateau
even within 2 h of exchange. However, peptides from the CTTs
(shown in red) exchanged much more rapidly, often reaching a
plateau before 5 s of exchange. This behavior was observed for
all three ErbB ICH constructs analyzed. This indicates that the
CTT region has faster hydrogen/deuterium exchange kinetics
than the kinase domain with amide hydrogen protection from
exchange being much weaker in the tail.
Comparisons between HDX data and the domain and secondary structure of EGFR, HER2, and HER3 are shown in Fig. 3.
The heat map was constructed by measuring deuterium uptake
in individual peptides and then on a residue by residue basis
across the entire sequence, averaging the %nex measurement of
all peptides covering specific amino acid residues. Residues and
time points with no acquired peptide coverage and proline residues are shown as gaps in the data. This averaging method
simplifies the observation of variations in deuterium exchange
protection for localized protein regions. In the EGFR heat map,
for example, we observe low exchange across much of the
kinase domain, indicated by blue coloring. Exceptions to this
observation include regions within the ␣C-helix and activation
loop (A-loop), which show more rapid exchange within the millisecond time scale of exchange, indicated by yellow colors. The
most striking result can be seen within the EGFR CTT where we
observe that exchange reaches a plateau very rapidly, often
within 5 s of exchange, and the %nex values are indicated by
JOURNAL OF BIOLOGICAL CHEMISTRY
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Polar uncharged
Ser
Thr
Asn
Gln
Subtotal

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered

FIGURE 3. HDX-MS heat maps for EGFR, HER2, and HER3 ICH constructs. Residue-specific average deuterium uptake data, 具%nex典, is mapped against
respective EGFR, HER2, and HER3 sequences. Deuterium uptake reaches a plateau much sooner in C-terminal tail regions when compared with the more
structured kinase domain. The EGFR sequence includes the 24-residue signal peptide in the numbering scheme. Similarly, the HER3 sequence numbering
includes the 19-residue signal peptide. The secondary structure of the kinase domain as determined by X-ray crystallography is shown plotted against the
sequence (Protein Data Bank codes 3PP0 for HER2, 3KEX for HER3, and 2GS2 for EGFR) (63– 65). The location of ␣C-helices and activation loops are also
identified.
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FIGURE 2. Example HDX-MS uptake curves for EGFR, HER2, and HER3. Selected peptides from the kinase domains or C-terminal tail of each protein are
shown in blue and red, respectively. Deuterium uptake reaches a plateau more quickly for the C-terminal tail as compared with the kinase domain. %nex is
calculated as the percentage of exchange relative to the maximum number of exchangeable amide hydrogens in each peptide normalized by the H2O:D2O
labeling ratio used in both labeling time course sets of experiments. Each data point represents the mean %nex value determined from triplicate measurements
with error bars representing the S.D. at each point.

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered

orange and red colors on the heat map. This rapid exchange
indicates that the tail is unprotected from exchange when compared with the kinase domain. The observed rapid exchange
behavior is characteristic of a highly dynamic and/or frequently
exchange-competent conformational state, meaning amide
hydrogen bonding between residues is transient or weak in
these regions.
Expression of EGFR and HER3 C-terminal Tails—To further
characterize the conformational and physical state of the EGFR
and HER3 CTTs, we expressed and purified EGFR and HER3
CTT-only constructs in a bacterial Escherichia coli system.
EGFR residues 961–1186 with a C-terminal His tag were purified using nickel-nitrilotriacetic acid column chromatography
and gel filtration. Estimated purity by SDS-PAGE was ⬎95%
(Fig. 4A) with a concentration of 5 mg ml⫺1. The HER3 CTT,
HER3 residues 981–1342, was also expressed in E. coli and purified to a concentration of 2 mg ml⫺1 with ⬎95% purity in the
same manner (Fig. 4B).
Confirmation of EGFR C-terminal Tail Function—Phosphorylation of the CTT region and subsequent binding of SH2
domain-containing proteins are essential steps in EGFR signalJANUARY 13, 2017 • VOLUME 292 • NUMBER 2

ing. We first validated the ability of our CTT constructs to be
both recognized and phosphorylated at specific tyrosine sites
by separate EGFR family kinase domains in solution just as they
would be if they were part of their respective ICH constructs.
To test whether the E. coli-expressed EGFR CTT construct is
functional, we incubated it with recombinant EGFR kinase
domain and measured tail phosphorylation using reaction with
ATP and blotting with phosphospecific antibodies. We show,
through Western blotting identification of specific phosphorylated tyrosine residues (EGFR Tyr-1068 and Tyr-1173) in the
EGFR CTT (Fig. 4C), that the EGFR CTT is recognized and
phosphorylated by the EGFR kinase domain even when these
two domains are expressed as separated constructs. Furthermore, we used anti-HER3 Tyr(P)-1289 and general PY20 antibodies to verify that the HER3 CTT was phosphorylated by
both the EGFR kinase domain and HER2 kinase domain via
Western blotting (Fig. 4D).
Next, we tested whether EGFR CTT can be bound by an
SH2 domain-containing protein. We recombinantly expressed
GST-tagged Grb2 SH2 domain and performed a GST pulldown
assay (Fig. 4E). Incubating EGFR CTT with EGFR kinase
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Purification and phosphorylation of CTT constructs. A, Coomassie-stained SDS-polyacrylamide gel of EGFR CTT purification. Lanes 1 and 4 are
molecular weight markers labeled respectively. Lane 2 is transformed cell lysate preinduction with IPTG. Lane 3 is lysate postinduction. Lane 5 is purified EGFR
CTT following Ni2⫹-chelating chromatography and gel filtration. EGFR CTT purity was determined to be ⬎95%. B, Coomassie-stained SDS-polyacrylamide gel
of HER3 CTT purification. This gel uses similar lane arrangement as in A for HER3 CTT expression. C, EGFR CTT is recognized and phosphorylated by the EGFR
kinase domain. Phosphospecific antibodies to EGFR Tyr(P)-1068 and EGFR Tyr(P)-1173 were used to detect CTT phosphorylation. D, Western blotting analysis
of HER3 CTT phosphorylation. The HER3 ICH serves as a positive control showing C-terminal tail phosphorylation via interaction with EGFR KD or HER2 KD. HER3
CTT is recognized and phosphorylated by the EGFR and HER2 kinase domains just as it would be as if it was part of its ICH construct. Phosphospecific antibodies
to HER3 Tyr(P)-1289 and general anti-phosphotyrosine PY20 were used to detect HER3 CTT phosphorylation. E, phosphorylated EGFR CTT binds to the Grb2
SH2 domain. GSH-agarose beads were preloaded with GST-tagged Grb2 SH2 domain protein. Phosphorylated or unphosphorylated EGFR CTT was then
incubated with the beads for 2 h at 4 °C, flow-through (FL) was collected and washed, and then the beads were boiled in sample buffer (Bound). Fractions were
separated by SDS-PAGE and then transferred to nitrocellulose. Anti-His6-HRP antibody was used to detect EGFR CTT in the FL and bound fractions.

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered
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FIGURE 5. Circular dichroism spectroscopy. A, the CD spectrum for the EGFR
CTT construct does not show prominent spectral features of ␣-helices and
␤-sheets. B, similarly, the HER3 CTT CD spectrum shows high unordered content with slightly higher calculated ␤-sheet content than in the EGFR CTT
spectrum. C, secondary structure assignment was assigned the following
symbols: regular ␣-helix (␣R), distorted ␣-helix (␣D), regular ␤-strand (␤R), distorted ␤-strand (␤D), turns (T), and unordered (U). deg, degrees.

detection inserted above. Our analysis shows that EGFR CTT
and carbonic anhydrase share similar molecular masses at 26
and 29 kDa, respectively, and both are monomeric under these
conditions. EGFR CTT elutes from the SEC column before 13
ml of buffer volume. Despite having a lower molecular weight,
the EGFR CTT elutes earlier than carbonic anhydrase, which
elutes just after 15 ml of buffer. The expected Stokes radius of
carbonic anhydrase is 2.4 nm (44). This earlier elution indicates
that the EGFR CTT conformational ensemble is more extended
than that of carbonic anhydrase, which has a globular structure.
Fig. 6B shows the SEC-MALS chromatogram profiles for HER3
CTT and EGFR kinase domain. The molecular masses, determined by MALS, of the HER CTT and EGFR kinase domain
were 42 and 38 kDa, respectively. HER3 CTT eluted at about 14
ml of buffer, which is earlier than the EGFR kinase domain,
which eluted between 16 and 17 ml of buffer. As with EGFR
CTT, no multimeric peaks were observed in the HER3 CTT
chromatogram.
VOLUME 292 • NUMBER 2 • JANUARY 13, 2017
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domain produced a phosphorylated CTT that appeared as multiple bands of higher molecular weight, and this phosphorylated
EGFR CTT did not bind on its own to glutathione-agarose (Fig.
4E, flow-through in lane 1 and bound in lane 2). Similarly, incubating unphosphorylated EGFR CTT with the GST-Grb2 SH2
domain construct did not result in binding, and EGFR CTT
eluted in the flow-through (lane 3). However, once phosphorylated, EGFR CTT was bound by GST-Grb2-SH2 and was
pulled down by glutathione-agarose (Fig. 4E, lane 6). These
experiments provide evidence for the functionality of the EGFR
and HER3 CTT constructs.
Analysis of EGFR CTT by CD Spectroscopy—Far-UV CD
spectroscopy provides information about the secondary structure characteristics of protein molecules in solution based on
the absorption of circularly polarized light by amide bonds in
the polypeptide backbone. Because secondary structure types
absorb circularly polarized light differently and each amide
bond contributes to the UV absorption, the resulting spectrum
will reflect a global average of the secondary structure content
in a protein. Due to a lack of ␣-helix and ␤-sheet content,
mostly or fully disordered and unfolded proteins will have CD
spectra that are distinct from highly ordered proteins. The CD
spectra between 190- and 260-nm wavelengths for EGFR CTT
and HER3 CTT are shown in Fig. 5, A and B, respectively. Distinctive features expected for a mostly ␤-strand protein would
include a positive ellipticity maximum at 195 nm with a negative ellipticity minimum near 215 nm. For a mostly ␣-helical
protein, one would expect two minima, one at 208 nm and the
other at 224-nm wavelength, along with a pronounced maximum near 192 nm (15, 41). However, the CD spectrum
observed for EGFR CTT shows a minimum between 195 and
200 nm, which is a characteristic of disordered proteins (Fig.
5A). However, the slightly negative ellipticity at 222 nm indicates the possibility of residual secondary structure. Analysis
via the CDSSTR algorithm, an algorithm used to assign secondary structure composition to CD spectra, shows 77% unordered
character in the EGFR CTT spectrum (Fig. 5C). These results
suggest that much of the EGFR CTT construct has an unfolded
conformation in solution. The CD spectrum for HER3 CTT
shows similar features as the EGFR CTT with a minimum
between 195 and 200 nm and slightly negative ellipticity at 222
nm (Fig. 5B). The HER3 CTT has mostly unordered content
(60%) but slightly higher ␤-sheet content than EGFR CTT: regular ␤-strand (␤R) ⫽ 15% and distorted ␤-strand (␤D) ⫽ 7% for
HER3 CTT as compared with ␤R ⫽ 6% and ␤D ⫽ 3% for EGFR
CTT (Fig. 5C).
Size Exclusion Chromatography with Multiangle Light
Scattering—Another property of intrinsically disordered regions is a higher than expected apparent molecular mass during
gel filtration separations (42). SEC can be used to separate proteins based on their hydrodynamic size, which is increased in
IDRs depending on the degree of conformational extension.
Proteins with higher hydrodynamic size elute earlier than
smaller proteins, and accurate, absolute measurement of
molecular weight can be obtained by coupling SEC to a MALS
detector (43).
Fig. 6A shows the SEC elution chromatograms for both the
EGFR CTT and carbonic anhydrase with the coupled MALS

EGFR and HER3 C-terminal Tails Are Intrinsically Disordered

Dynamic Light Scattering—The DLS technique is used to
analyze hydrodynamic properties of proteins in solution. Using
the hydrodynamic radius, or Stokes radius, derived from measurements of translational diffusion coefficients, we are able to
differentiate between a protein ensemble with mostly compact,
globular conformations and one with more extended conformations as would be seen for IDRs (45). DLS is complementary
to the static light scattering used in SEC-MALS in that DLS
provides information on molecular size, whereas MALS provides a molecular weight and verification of a monomeric state.
A histogram showing a distribution of measured hydrodynamic
radii within the EGFR CTT and bovine serum albumin (BSA)
populations is shown in Fig. 6C. The EGFR CTT, which has a
molecular mass of 26 kDa, was determined to have a hydrodynamic radius of 5.3 nm. For a comparison, we also analyzed
JANUARY 13, 2017 • VOLUME 292 • NUMBER 2

BSA, a globular protein with a molecular mass of 66 kDa, and
the hydrodynamic radius of BSA was measured to be 4.8 nm.
This demonstrates that EGFR CTT has a larger hydrodynamic
radius than a globular protein more than 2.5 times its size. Similarly, HER3 CTT has a very large hydrodynamic radius (Fig.
6D). The hydrodynamic radius (RH) of HER3 CTT is 6.4 nm,
although it has higher polydispersity than EGFR CTT.
Analytical Ultracentrifugation—We used sedimentation
velocity AUC to determine the sedimentation coefficient, s, of
EGFR CTT, which provides information about the molecular
weight of the tail, Mf, as it relates to its RH (Fig. 6E). We also
determined that our sample is homogenous due to the absence
of secondary peaks in Fig. 6C as secondary populations or
impurities would have different sedimentation velocities. From
these AUC measurements, we obtained the frictional coeffiJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Hydrodynamic properties of EGFR and HER3 CTT. A, elution chromatograms and molecule weight determination of EGFR CTT by SEC-MALS. EGFR
CTT data are shown in red, and carbonic anhydrase data are shown in blue. Despite similar molecular weights, EGFR CTT elutes sooner, indicating a larger
hydrodynamic size. B, SEC-MALS analysis of HER3 CTT. HER3 CTT data are shown in red, and EGFR kinase domain data are shown in blue. Again, the two
molecules share similar molecular weights, but HER3 CTT elutes sooner than the EGFR KD. C, hydrodynamic radius determination of the EGFR CTT and BSA by
dynamic light scattering. The measured DLS hydrodynamic radius distribution for EGFR CTT is shown as yellow bars. The measured hydrodynamic radius of
EGFR CTT is 5.3 nm. The histogram for BSA (monomeric fraction obtained by gel filtration) is shown as red bars. The Rh of monomeric BSA is 4.8 nm. D,
hydrodynamic radius determination of the HER3 CTT. The measured DLS hydrodynamic radius for HER3 CTT is 6.4 nm. E, frictional coefficient, frictional ratio,
and molecular weight determined by analytical ultracentrifugation. The sedimentation coefficient was used to measure an apparent molecular mass, Mf, of
23.5 kDa. The frictional ratio for the EGFR CTT is 1.77, indicating a large Stokes radius relative to globular proteins. F, frictional coefficient, frictional ratio, and
molecular weight determined by analytical ultracentrifugation. The measured apparent molecular mass of HER3CTT is 31.6 kDa. The frictional ratio is 1.52.
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cient of the tail, f, which can be used to relate its molecular
shape to that of a globular protein. The frictional ratio, f/fmin,
provides an indication of the shape of a macromolecule based
on the ratio of its measured frictional coefficient to a theoretical
minimum frictional coefficient for a particle with minimum
Stokes radius at a given molar mass (46). For a globular protein,
the expected f/fmin would fall between 1.15 and 1.3 (47– 49). We
determined the f/fmin value for EGFR CTT to be much greater,
at 1.77, which is consistent with this being an IDR. Similarly,
HER3 CTT has a f/fmin value of 1.52, which is also greater than
the expected frictional ratio for globular proteins (Fig. 6F).
Small Angle X-ray Scattering—Small angle X-ray scattering
methods have been particularly useful in analyzing conformation ensemble properties of IDRs (50). In small angle X-ray
scattering analyses, we measured the isotropic scattering
intensity, I(s), as a function of the momentum transfer, s, of
monochromatic X-ray light diffracted by protein macromolecules in solution. In protein structure studies, SAXS has been
used to characterize structure and dynamics of monodisperse
molecular species with a dominating structural configuration.
IDRs show larger average sizes compared with globular proteins that contain tightly packed cores. By comparing the measured Rg and Dmax from SAXS with other known structured
globular proteins, together with Kratky plots (I(s)䡠s2 as a function of s), which characterizes the flexibility state of the proteins, one is able to identify the flexibility of the IDRs (51). Fig.
7A shows the scattering profiles for EGFR CTT and BSA. In Fig.
7B, Guinier plot regions of EGFR CTT in three different concentrations are shown. Rg values calculated by AutoRg (52) are
46.6 ⫾ 2.2 (EGFR CTT) and 33.6 ⫾ 0.6 Å (BSA), and the molecular masses for each of them are 25.6 ⫾ 0.7 and 69.0 ⫾ 2.0 kDa,
respectively (Table 2). The Kratky plot (Fig. 7C) of BSA shows a
parabolic shape with a well defined peak. In contrast, EGFR
CTT shows a hyperbolic shape on the Kratky plot, indicating an
intrinsically disordered region (Fig. 7C). Fig. 7D shows the pair
distribution function (P(r)) of EGFR CTT generated by Datgnom (52). The Dmax of EGFR CTT is 156 ⫾ 6 Å, which is much
larger than that of BSA (Table 2). Thus, the Rg and Dmax measurements, Kratky plot, and P(r) distribution of EGFR CTT
indicate that the conformational ensemble adopted by EGFR
CTT is extended and flexible.
When we analyzed the HER3 CTT with SAXS, we also
included samples containing urea to determine whether a
chemical denaturant would have an effect on the conformational ensemble. It is also important to note that, unlike in
EGFR CTT buffer, 5% glycerol was also included in the HER3
CTT buffer. The glycerol was necessary to maintain protein
solubility and stability of the HER3 CTT, but it may also act to
stabilize conformations with diminished extendedness. We do
not directly compare derived Rg values between EGFR CTT and
HER3 CTT because of this difference in buffer conditions. The
scattering profiles for HER3 CTT without urea and with 4 M
urea are shown in Fig. 8A, and Guinier plot regions are shown in
Fig. 8B. From these data, we calculated an Rg of 45.4 ⫾ 0.4 Å in
the absence of urea, and that increases slightly to 50.5 ⫾ 1.2 Å
upon the addition of 4 M urea (Table 2). The derived Kratky
profiles for these two conditions are shown in Fig. 8C. Without
urea present, the HER3 CTT produces a slightly parabolic

FIGURE 7. Small angle X-ray scattering analysis of EGFR CTT. A, scattering
profiles of EGFR CTT (red) and BSA (blue). B, Guinier plots of EGFR CTT in
different concentrations (0.9, 1.8, and 3.7 mg ml⫺1). C, the data are represented in a Kratky plot with arbitrary units. In folded proteins like BSA (blue),
the Kratky plot shows parabolic features, whereas in the EGFR CTT Kratky plot
(red), a hyperbolic shape indicates intrinsically disordered protein character.
D, pair distribution functions for the EGFR CTT (red) and BSA (blue) scattering
profiles generated using Datgnom (52).
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TABLE 2
Structural parameters obtained by SAXS
Construct

Predicted molecular
massa

EGFR CTTc
HER3 CTTe
HER3 CTT ⫹ ureae
BSA
EGFR kinase domain (Protein Data Bank code 1XKK)f

26.2
40.5
40.5
66.5
41.1

Number of
amino acids

Measured molecular
massb
kDa

Å

Å

235
371
371
583
352

25.6 ⫾ 0.7
41.5 ⫾ 0.8
36 ⫾ 4
69 ⫾ 2
41.1

46.6 ⫾ 2.2
45.4 ⫾ 0.4
50.5 ⫾ 1.2
33.6 ⫾ 0.6
20

156 ⫾ 6d
153 ⫾ 9d
164 ⫾ 10d
114 ⫾ 5
64

kDa

Rg

Dmax

a

Values were calculated based on protein amino acid sequences.
Measured molecular mass was calculated from the X-ray scattering profile.
Buffer for EGFR CTT was 20 mM phosphate, pH 8.0, 150 mM NaCl.
d
Characteristics of intrinsically disordered proteins are shown in the Kratky plots for these constructs.
e
Buffer for HER3 CTT was 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 5% glycerol, ⫹/⫺4 M urea as indicated above.
f
Values of EGFR kinase domain were calculated from a theoretical scattering profile generated by the CRYSOL program using the crystal structure of EGFR kinase domain
(Protein Data Bank code 1XKK).
b
c

FIGURE 8. Small angle X-ray scattering analysis of HER3 CTT in solution ⴞ
urea. A, scattering profiles of HER3 CTT in solution without urea (blue) and
with 4 M urea (red). B, Guinier plots of HER3 CTT with or without the presence of 4 M urea. C, the data are represented in a Kratky plot with arbitrary
units. The Kratky plot for HER3 CTT with 4 M urea added shows a more
hyperbolic profile, indicating greater disorder with the addition of chemical denaturant.
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Discussion
We have shown that the CTT domains in EGFR family proteins are intrinsically disordered regions that have an extended,
highly dynamic conformational state. HDX-MS demonstrates
that the CTT domains have a highly dynamic and exchangecompetent conformation. CD spectroscopy shows that they
have high unordered character as expected for IDRs. SEC and
DLS demonstrate that hydrodynamic size of the CTT is larger
than protein standards of comparable molecular weight, which
is another property of IDRs. AUC and the Kratky plot from
SAXS demonstrate that the CTTs are IDRs, and Rg and Dmax
measurements from SAXS demonstrate that the CTTs have an
extended conformation. The Rg and Dmax measurements of the
EGFR kinase domain were estimated from crystal structure
(Protein Data Bank code 1XKK), and we observed that the
EGFR CTT had Rg and Dmax values that were ⬃2.4 times larger
than those of the EGFR kinase domain.
A striking finding on the EGFR and HER3 CTTs is that
despite their low primary sequence homology (22% sequence
identity) the structural features of the CTTs are strongly conserved. This implies that the intrinsic disorder of these tails is
important for their function, and the multiple conformers that
a disordered region can adopt could reduce the thermodynamic
barriers for protein binding and thereby increase both the onand off-rates for binding of SH2 domain-containing proteins.
Furthermore, the extended conformation of the CTT could
increase the capture radius for recruitment of these signaling
proteins (53, 54). Both of these mechanisms would facilitate
signal propagation by these receptor tyrosine kinases.
The intrinsically disordered properties of these CTTs also
explain why these regions are mostly absent from crystallographic studies on EGFR (7, 55). Portions of the EGFR tail
located close to the kinase domain have been shown to be
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Kratky profile, with a defined local maximum observed, at
lower momentum transfer values. Moving toward greater
momentum transfer values then gives a more hyperbolic
increase in I(s)䡠s2. For HER3 CTT with 4 M urea, the Kratky
profile has a hyperbolic shape indicative of disorder, similar to
the profile observed for the EGFR CTT (Fig. 7C). The difference
in Kratky plots between HER3 CTT with or without urea,
together with increased Rg, indicates that HER3 CTT possesses
characteristics of IDRs but not of random coil structures when
in solution.
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Experimental Procedures
EGFR/ErbB Family Protein Expression and Purifications—
The following protein constructs were prepared for HDX-MS
experiments and/or Western blotting analyses: EGFR WT ICH
(668 –1210; 644 –1186 without signal peptide numbering),
HER2 V956R mutant ICH (676 –1255), HER3 WT ICH (664 –
1342; 645–1323 without signal peptide numbering), EGFR WT
kinase domain (696 –1022; 672–998 without signal peptide
numbering), and HER2 WT kinase domain (704 –1029). The
protein expression procedure was adapted from protocols
described previously (57, 58). Briefly, DNA encoding for each
construct was cloned into separate pFastBacHT vectors (Invitrogen). Site-directed mutagenesis was conducted using the
QuikChange II procedure (Agilent). Construct integrity was
confirmed by DNA sequencing. The Bac-to-Bac protocol
(Invitrogen) was used to make recombinant baculovirus for
subsequent one multiplicity of infection of Spodoptera frugiperda Sf9 cells. Cells were harvested 48 h postinfection. Lysis
of pelleted cells, purification of protein constructs via nickelnitrilotriacetic acid resin, and gel filtration via Superdex-200
were repeated as reported previously (57, 58). ICH constructs were purified into buffer containing 20 mM Tris, 150
mM sodium chloride, 10% (w/v) glycerol, 0.01% Tween 20, 1
mM DTT, pH 8.0.
Hydrogen/Deuterium Exchange Mass Spectrometry—In HDXMS experiments, we used a database of pepsin-digested peptide
fragments found and identified via mass spectrometry to measure localized deuterium uptake in a protein. EGFR, HER2, and
HER3 ICH construct stock solutions were each transferred into
200 l of 0.1% TFA to a concentration of 1 M and passed
through an immobilized pepsin column (59). 30 l of each collected digested protein eluent was analyzed by electrospray tandem mass spectrometry (MS/MS) using an LTQ FT Ultra mass
spectrometer (Thermo Finnigan). A Mascot peptide search was
used to build three peptic peptide databases, one for each protein, for subsequent MS analyses.
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In the HDX experiments, EGFR, HER2, and HER3 ICH
stocks were diluted into an H2O solvent protein storage buffer
of 20 mM HEPES, 150 mM NaCl, pH 7.4. The concentration of
protein prior to labeling was between 0.1 and 0.2 mg ml⫺1 for all
experiments. A matching D2O solvent labeling buffer with 20
mM HEPES, 150 mM NaCl, pD 7.4, was used to label the protein
samples for a set exposure time at room temperature.
HDX samples were prepared in triplicate as two sets. The
first set was prepared via quench flow (QF) using a 1:5 volume
ratio between protein sample in H2O solvent protein storage
buffer and D2O labeling buffer with D2O exposure times
between 108 and 2333 ms (36). For the second set of samples
with D2O exposure times between 5 and 7200 s, protein samples were diluted in a 1:20 ratio of 2 l of H2O protein storage
buffer and 40 l of D2O labeling buffer via manual labeling
(ML).
In each sample, following the measured exposure time for
exchange, a quench solution of equal volume to the D2O buffer
of 0.4% formic acid and 3 M urea was used to lower the sample
pH to about 2.6 to halt the forward exchange reaction and minimize back-exchange of deuterium-labeled amides for solvent
hydrogen. Quenched samples were then flash frozen in liquid
nitrogen and stored at ⫺80 °C until we were ready to run online
digestion and HPLC separation. Pepsin digestion was performed via an immobilized pepsin column. Separation of peptides was accomplished using a water/acetonitrile gradient
across a Poroshell 120 EC-C18 2.1 ⫻ 50-mm analytical column
(Agilent Technologies) prior to mass spectrometry analysis on
a Bruker MaXis 4G electrospray ionization quadrupole timeof-flight mass spectrometer (Bruker Corp.). All chromatography solvents contained 0.1% formic acid.
HDX-MS data were analyzed using HDExaminer software
(Sierra Analytics). A measurement of deuterium uptake, ⌬m,
was made by calculating the average mass for a specific peptide’s isotopic envelope at each HDX time point, mt, and subtracting the average mass of an undeuterated control’s isotopic
envelope, mund. Samples were analyzed in triplicate, and mass
increase measurements presented throughout this work are the
average uptake measurements for available data from these
triplicate sample runs, ⌬mavg. The maximum number of
exchangeable amide hydrogens, namide, was calculated for each
observed peptic peptide in the peptide databases. The first two
residues are not included among the exchangeable amide
hydrogens due to rapid back-exchange of the deuterium label
for these residues (32, 60, 61). Similarly, proline residues are
excluded because of their lack of peptide chain amide hydrogen.
Because of the 1:5 H2O:D2O labeling ratio, the maximum
observable exchange would be 83.3% of namide for samples prepared with QF. Similarly, the maximum observable exchange
would be 95.2% namide for samples prepared through ML. HDX
data collected by MS were normalized to a maximum observable exchange, nex, in both QF (Equation 1) and ML (Equation
2) data sets based on these maximum observable exchange
values.
n ex,QF ⫽

⌬mavg,QF 6
⫻
namide
5

(Eq. 1)
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responsible for EGFR autoinhibition (56). The deletion of residues 982–1054 in the EGFR vIVb mutant is of particular importance in downstream signaling and kinase activation and has
been shown to promote tumor formation. This region has been
characterized via crystallography as containing an AP2-helix
and other secondary structure elements, which appear to interact with the kinase domain in a manner that inhibits activation
(4, 55, 56). In a study by Kovacs et al. (55), serial deletions of tail
regions revealed specific regions important for autoinhibition
as they relate to the oncogenic vIVb mutation. We observe
increased protection from deuterium exchange for the EGFR
982–1054 region in the HDX-MS heat map (Fig. 3) relative to
the rest of the C-terminal tail. The application of HDX-MS
allows us to locally characterize conformational properties for
protein regions that may not be easily analyzable with crystallography. In conclusion, these methods demonstrate that the
EGFR and HER3 CTTs are IDRs with extended, non-globular
structure in solution, and this finding may have important
implications for the recruitment of downstream signaling proteins and signal propagation from these RTKs.
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n ex,ML ⫽

⌬mavg,ML 21
⫻
namide
20

(Eq. 2)
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A deuterium uptake heat map for EGFR, HER2, and HER3
was generated using the residue by residue average, 具%nex典, of
representative peptides’ %nex measurements at each time point
(Fig. 3) (36, 62). This residue-specific averaging shows more
localized HDX information across entire ICH protein sequences and accounts for overlapping peptide data. Peptides
were not weighted based on their respective lengths. The
sequences of EGFR, HER2, and HER3 were each aligned to crystallographic secondary structure assignments of respective
kinases domains. The crystal structures used were Protein Data
Bank codes 3PP0 for HER2, 3KEX for HER3, and 2GS2 for
EGFR (63– 65).
Expression and Purification of EGFR CTT and HER3 CTT—
DNA encoding residues 961–1186 of the human EGFR were
cloned into a pET30b vector using NdeI and XhoI restriction
sites in-frame with a C-terminal His tag in the vector. The
E. coli strain BL21(DE3) was used for expression of the construct. Transformed cells were grown in Luria-Bertani medium
containing 50 g ml⫺1 kanamycin at 37 °C until an OD600 of
between 0.5 and 0.8 was reached. Expression was induced
through the addition of 0.5 mM isopropyl ␤-D-1-thiogalactopyranoside (IPTG) for 3 h at 37 °C. Bacterial cells were centrifuged, and the pellets were frozen. Cell lysis was performed at
4 °C with a probe sonicator on frozen pellets using 50 mM
sodium phosphate, pH 8.0, 300 mM NaCl, 20 mM imidazole, 1
mM phenylmethylsulfonyl fluoride (PMSF), 1 mM ␤-mercaptoethanol, Roche Applied Science protease inhibitor mixture tablets, 4 mM benzamidine䡠HCl. The lysate was clarified by centrifugation at 48,000 ⫻ g for 30 min at 4 °C. Purification was
performed using Ni2⫹-chelating chromatography followed by
gel filtration chromatography on a Superdex-75 column. The
protein was concentrated to 5 mg ml⫺1 in 20 mM phosphate,
150 mM sodium chloride, pH 8.0. Aliquots were snap frozen in
liquid N2 and stored at ⫺80 °C. Protein concentration was
determined using UV-visible spectroscopy with a molar extinction coefficient of EGFR CTT at 280 nm of ⑀ ⫽ 18,910 M⫺1
cm⫺1. For specific subsequent applications, the addition of
DTT or tris(2-carboxyethyl)phosphine to EGFR CTT samples
was critical. A similar procedure was followed to express and
purify a HER3 CTT construct with residues 981–1342. The
HER3 CTT was purified at a concentration of 2 mg ml⫺1 in 20
mM Tris, 300 mM sodium chloride, 5% (w/v) glycerol, pH 8.0.
HER3 CTT concentration was determined using a molar
extinction coefficient at 280 nm of ⑀ ⫽ 25,245 M⫺1 cm⫺1.
C-terminal Tail Function via Western Blotting Analysis—
EGFR CTT was phosphorylated via reaction in 0.1 mM ATP, 0.1
mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM MnCl2
catalyst. EGFR CTT concentrations of 0.25 and 0.50 M tail
were incubated in the presence of 0.50 M EGFR kinase
domain. Two negative controls were also incubated under the
same conditions with the following exceptions: 0.50 M CTT
was incubated without kinase domain present, and separately
0.50 M kinase domain was incubated without CTT present. A
positive control of ATP phosphorylation of 0.50 M EGFR ICH

construct, which contains both kinase domain and CTT
regions together, was also incubated.
Two EGFR tail region-specific phosphotyrosines were analyzed by Western blotting. Following the phosphorylation reaction, EGFR CTT samples were separated by SDS-PAGE on a
10% polyacrylamide gel followed by electroblotting onto nitrocellulose membrane. Two anti-EGFR phosphotyrosine primary
antibodies were used in separate Western blotting analyses:
1:1000 anti-EGFR Tyr(P)-1068 and 1:5000 anti-EGFR Tyr(P)1173. Secondary antibody was 1:5000 anti-rabbit in both blots.
The results of the Western blotting analyses are shown in Fig.
4C. The positive control was also analyzed on the same two
Western blots as the EGFR CTT samples. Bands from this positive control were observed on both Western blots but are not
shown herein.
HER3 CTT was phosphorylated via the same buffer conditions as the EGFR CTT above. HER3 CTT at 0.50 M was incubated in the presence of 0.50 M EGFR or 0.50 M HER2 kinase
domains. Negative controls were incubated under the same
conditions where only CTT or kinase domain was incubated in
each case. Positive controls pairing HER3 ICH with EGFR
kinase domain or HER2 kinase domain were also incubated.
Samples were separated by SDS-PAGE and electroblotted onto
nitrocellulose membrane. 1:1000 anti-HER3 Tyr(P)-1289 primary with 1:10,000 anti-rabbit secondary antibodies were used
for the first blot. A 1:1000 general anti-phosphotyrosine antibody, PY20, was used for the second blot with 1:10,000 antimouse secondary antibody. The two Western blots are shown
in Fig. 4D.
GST-Grb2-SH2 Expression and Purification—pGEX Grb2SH2 (amino acids 58 –159) was purchased from Addgene (plasmid 46440, deposited by Dr. Bruce Mayer). BL21(DE3) cells
were transformed, and a colony was picked and used to inoculate a 100-ml LB ⫹ ampicillin culture. The culture was induced
to midlog phase with 1 mM IPTG for 2 h at 37 °C. Pellets were
collected and subsequently frozen at ⫺80 °C. GST-Grb2-SH2
was purified using glutathione-agarose beads (Sigma). Fractions were eluted with reduced glutathione, pooled, dialyzed,
and concentrated using an Amicon 10,000 molecular weight
cutoff spin concentrator in 20 mM Tris-HCl, pH 8 (4 °C), 150
mM NaCl, 1 mM DTT. Aliquots were flash frozen and stored at
⫺80 °C.
Interaction of Phosphorylated EGFR CTT and GST-Grb2SH2 by Pulldown Assay—EGFR CTT was phosphorylated by
EGFR KD in vitro for 60 min at room temperature. 10 g of
GST-Grb2-SH2 was prebound to a 10-l bed volume of glutathione-agarose beads. 2 g of either phosphorylated CTT or
non-phosphorylated CTT was added to the beads in a volume
of 100 l of buffer and incubated for 2 h at 4 °C. Beads were then
spun briefly and the flow-through (FL) was collected. This was
followed by two washes with buffer. Beads (bound) and aliquots
of the FL were then boiled in SDS-PAGE sample buffer. Western blotting was done on the fractions using anti-His6-HRP
antibody (Thermo Fisher, MA1-21314-HRP) as a probe.
Circular Dichroism Spectroscopy—EGFR CTT protein was
prepared at a concentration of 5 M in 10 mM sodium phosphate, pH 7.4, 5 mM NaCl. HER3 CTT was also prepared at the
same conditions. A 0.1-cm pathlength quartz cell was used for
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experiments ranged from 0.9 to 3.7 mg ml⫺1. BSA in 20 mM
phosphate, pH 8.0, 150 mM NaCl was used as a standard in the
range of 1.0 –3.0 mg ml⫺1. The concentration of HER3 CTT (20
mM Tris-HCl, pH 8.0, 300 mM NaCl, 5% glycerol) ranged from
0.9 to 1.5 mg ml⫺1. A minimum of three different concentrations for each protein were used for data collection, and five
different concentrations were used for EGFR CTT.
The data sets were processed using standard procedures for
ATSAS programs (52). At low angles, the scattered intensities
of EGFR CTT and HER3 CTT were very well approximated by
the Guinier law, whereas HER3 CTT showed signs of radiation
damage at 5-s exposures. Before further analysis, the scattering
curves, free of radiation damage, from a given type of sample
with the same protein concentration but different exposure
times were merged with either PRIMUS (52) or SCÅTTER
(SIBYLS Beamline at Lawrence Berkeley National Laboratory)
and then averaged among the same type of sample after normalization using their individual protein concentration. The
average scattering curves are presented in Figs. 7A and 8A. The
Rg from data sets free of radiation damage was calculated using
AutoRg and is presented in Table 2. We evaluated the molecular weight of the sample by comparing the forward scattering
I(0) with that from a reference solution of BSA. The Rg and Dmax
values for EGFR kinase domain (Protein Data Bank code 1XKK)
were calculated using the program CRYSOL (73). The pair distribution functions for EGFR CTT and BSA were generated
using Datgnom (52).
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